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Wdr5 accelerates osteoblast and chondrocyte differentiation in vitro, and is developmentally expressed in osteoblasts as well as in proliferating
and hypertrophic chondrocytes. To investigate the role of Wdr5 during endochondral bone development, transgenic mice overexpressing Wdr5
under the control of the 2.3-kb fragment of the mouse α(1) I collagen promoter were generated. The transgene was specifically expressed in the
osteoblasts of transgene positive mice and was absent in the growth plate. Histological analyses at embryonic day 14.5 demonstrated that the
humeri of transgene positive embryos were longer than those isolated from wild-type littermates largely due to an expansion of the hypertrophic
chondrocyte layer. Acceleration of osteoblast differentiation was observed with greater and more extensive expression of type I collagen and more
extensive mineral deposition in the bone collar of transgene positive embryos. Acceleration of vascular invasion was also observed in transgene
positive mice. Postnatal analyses of transgenic mice confirmed persistent acceleration of osteoblast differentiation. Targeted expression of Wdr5 to
osteoblasts resulted in earlier activation of the canonical Wnt signaling pathway in the bone collar as well as in primary calvarial osteoblast
cultures. In addition, overexpression of Wdr5 increased the expression of OPG, a target of the canonical Wnt signaling pathway. Overall, our
findings suggest that Wdr5 accelerates osteoblast differentiation in association with activation of the canonical Wnt pathway.
© 2006 Elsevier Inc. All rights reserved.Keywords: Wdr5; BIG-3; Endochondral bone formation; Wnt signaling; Osteoblasts; Differentiation; OsteoprotegerinIntroduction
Skeletal development in vivo occurs via two major
processes, intramembranous and endochondral ossification.
Both intramembranous and endochondral ossifications begin
with condensation of mesenchymal cells that form a template
for the skeleton and end with formation of a mineralized
skeleton. However, while intramembranous ossification occurs
by direct differentiation of mesenchymal cells into osteoblasts,
endochondral bone formation is a multistep process where
chondrocytes form a mould, in which vascular invasion occurs
followed by formation of an ossification center containing type I
collagen-expressing osteoblasts. At the molecular level, several
factors are known to cooperate in regulating the sequential steps
of endochondral bone formation (Kronenberg, 2003), including
the bone morphogenetic protein (BMP) (Canalis et al., 2003;⁎ Corresponding author. Fax: +1 617 726 7543.
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Kronenberg, 2003), parathyroid hormone-related peptide
(PTHrP), Indian Hedgehog (Ihh) (Chung et al., 1998, 2001;
Karaplis et al., 1994; Karp et al., 2000; Kobayashi et al., 2002;
Kronenberg, 2003; Lanske et al., 1999; Schipani et al., 1997; St-
Jacques et al., 1999; Vortkamp et al., 1996), fibroblast growth
factor (FGF) (Colvin et al., 1996; Kronenberg, 2003; Ornitz,
2005; Wang et al., 1999) and Wnt signaling pathways among
others (Akiyama et al., 2004; Glass et al., 2005; Hartmann and
Tabin, 2000; Hu et al., 2005; Kawakami et al., 1999, 2000;
Westendorf et al., 2004; Yamaguchi et al., 1999).
We identified a novel BMP-2-induced gene named BIG-3
(BMP-2 Induced Gene 3kb) and recently renamed Wdr5, that
dramatically accelerates the program of osteoblastic differenti-
ation in MC3T3-E1 cells. Wdr5 encodes a protein belonging to
the family of the WD-40 proteins. This family of proteins has
been shown to play a role in numerous cellular functions
including signal transduction, mRNA processing, gene regula-
tion, vesicular trafficking and cell cycle regulation (Neer et al.,
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expressed in immortalized marrow stromal cells, osteoblasts,
osteocytes and chondrocytes (Gori et al., 2001). Overexpression
of Wdr5 dramatically accelerates the program of osteoblast and
chondrocyte differentiation in cell culture models and is
developmentally expressed in osteoblasts as well as in
proliferative and hypertrophic chondrocytes during endochon-
dral bone formation (Gori and Demay, 2004; Gori et al., 2001).
To investigate whether Wdr5 has a functional role during
endochondral bone formation in vivo, transgenic mice over-
expressing Wdr5 under the control of the 2.3-kb fragment of the
mouse α (1) I collagen promoter were generated. These studies
demonstrate that overexpression of Wdr5 accelerates osteoblast
differentiation and maturation by activating the canonical Wnt
signaling pathway during skeletal development. An expansion
of the hypertrophic chondrocyte layer is also observed,
suggesting that Wdr5 expressed in the bone collar has paracrine
actions on chondrocyte differentiation.
Materials and methods
Generation and identification of transgenic mice
Transgenic mice, overexpressing Wdr5 under the control of the 2.3-kb
fragment of the mouse α(1) I collagen promoter (Col I–Wdr5), were generated.
The coding region of Wdr5 (1.9 Kb) was substituted for the lacZ gene in the
plasmid pJ251 (a gift of Dr. Benoit de Crombrugghe, University of Texas, M.D.
Anderson Cancer Center, Houston, TX, USA). This vector provides a 3′ intron
and polyadenylation signal for the transgene, the latter of which was used as a
probe for in situ hybridization analyses to distinguish the transgene from the
endogenous transcript. An XhoI–HindIII fragment containing the 2.3-kb
fragment of the mouse α(1) I collagen promoter, the coding region of Wdr5
and the 500bp mouse protamine gene intron and polyadenylation signal (Fig.
1A) was isolated from the vector sequences and purified according to standard
techniques. Pronuclear injections of fertilized mouse oocytes from FVB/N
females were performed. Potential founders were screened by PCR analyses of
genomic DNA isolated from tails using F1 and R1 primers (Fig. 1A) and
subsequently by Southern analyses using PstI digested genomic DNA probed
with a 32P-labeled 1100bp ApoI fragment of Wdr5 (probe A in Fig. 1A), to
identify those with a single transgene integration site. All studies were approved
by the institutional animal care committee. Mice were maintained in a virus and
parasite-free barrier facility and exposed to a 12h light/dark cycle.Fig. 1. Generation of transgenic mice. (A) Schematic representation of the transgene c
tail genomic DNA and Probe A and Probe B used for Southern and in situ hybridizati
(B) Northern Analyses. Total RNA, isolated from calvaria of 3-day-old offspring froNorthern analyses
Transgene expression was evaluated by Northern analysis of RNA
isolated from calvariae of offspring from potential founders. Ten micro-
grams of total RNA was resolved on a 1% agarose/formaldehyde gel and
transferred to a nylon membrane (Biotrans ICN, Aurora, OH) by capillary
blotting. Probes were radiolabeled with [α-32P] dATP (Dupont New England
Nuclear, Boston, MA) to a specific activity of ≥108cpm/ng DNA
(Megaprime™ DNA labeling systems, Amersham Piscataway, NJ).
Alcian Blue and Alizarin Red staining
Day 14.5 fetuses were fixed in 95% ethanol. After 5 days, specimens
were transferred to acetone for an additional 7 days. The specimens were
then stained with 0.3% Alcian Blue 8GS (Sigma, St. Louis, MO) in 70%
ethanol and 1% Alizarin Red S (Sigma, St. Louis, MO) in 95% ethanol for
3 days at 37°C. Specimens were transferred to 1% KOH until the skeletons
were clearly visible. Specimens were then incubated in 1% KOH containing
increasing concentrations of glycerol (20%, 50% and 80% glycerol) over a
period of 4 weeks.
Histological evaluation
Limbs from 14.5dpc embryos, neonatal and 7- and 9-day-old mice were
fixed in 10% neutral buffered formalin followed by dehydration and
paraffin embedding. Tissue blocks were cut into 6μm sections, deparaffi-
nized and rehydrated. Forelimb sections were stained with hematoxylin and
eosin (H&E) or von Kossa stained to permit phenotypic analyses.
Measurements for the length of the humeri and the size of the flat and
round proliferating chondrocytes layer and hypertrophic chondrocyte layer
were performed using microscope software.
Immunohistochemistry
Immunohistochemical analyses were performed on forelimb sections
isolated from 14.5dpc embryos using anti-CD31(BD Biosciences, Franklin
Lakes, NJ, USA) or a non-specific mouse IgG and on tibiae isolated from
newborn mice using anti-Wdr5 (Gori and Demay, 2004) or a non-specific
rabbit IgG (Sigma, St Louis, MO) and the TSA Biotin System Kit
(PerkinElmer, Boston, MA). Immunoreactive proteins were visualized using
Streptavidin HRP and Streptavidin Texas Red (PerkinElmer, Boston, MA).
To examine activation of the Wnt signaling pathway during development,
immunohistochemistry was performed using anti-β-catenin (BD Biosciences,
Franklin Lakes, NJ, USA). Frozen sections isolated from 14.5dpc forelmbs
were incubated at room temperature with anti-β-catenin or a non-specificonstruct showing the position of the oligonucleotides F1 and R1 used for PCR of
on analyses, respectively. Restriction sites for BamHI and PstI are also indicated.
m two founders (TgA and TgB) and a control wt (control) mouse.
Fig. 2. Expression of the transgene. (A) Wdr5 antisense riboprobe was
radiolabeled with 35S-UTP to a specific activity of at least 108cpm/μg of
template. Dark-field photographs of proximal tibiae of wild-type (wt), het Col I–
Wdr5 and hom Col I–Wdr5 newborns. Arrows indicate the expression of the
transgene in the bone collar, periosteum and trabecular bone. There is no
detectable expression of the transgene in the chondrocytes. (B) Immunohisto-
chemistry on tibiae from newborn mice was performed using α-Wdr5.
Endogenous Wdr5 is expressed in proliferating chondrocytes, hypertrophic
chondrocytes, the periosteum and trabecular bone. Representative hindlimbs of
three mice are shown.
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slides were washed in PBS and incubated with antimouse IgG-FITC (Santa
Cruz Biotechnology, Santa Cruz, CA) for 1h to visualize immunoreactive
proteins.
In situ hybridization
Riboprobes were radiolabeled with 35S-UTP to a specific activity of at
least 108cpm/μg of riboprobe template. Hybridization was performed at
55°C for 20h in 50% formamide, 10mM Tris–HCl pH 7.6, 200μg/ml
tRNA, 1× Denhardt's solution, 10% dextran sulfate, 600mM NaCl, 0.25%
SDS and 50mM DTT. Sequential washes with graded stringency were
performed, following which slides were dipped in photoemulsion (Autora-
diography Emulsion, Type NTB, Kodak, Rochester NY) and exposed at
4°C for 6 to 14 days. The slides were developed and counter-stained with
H&E to identify the cellular source of the signal.
β-gal staining
Embryonic day 14.5 offspring of TOPGAL (Jackson Institute, Bar
Harbor, ME) mice and Col I–Wdr5 mice (Col I–Wdr5;TOPGAL), were
fixed in 2% paraformaldeyde pH 7.1 and 0.02% glutaraldehyde pH 7.1.
After 1h, embryos were rinsed with PBS and stained with a solution of
20mg/ml X-gal (American Bioanalytical Natick, MA), 0.25M EGTA
(Sigma, St Louis, MO), 0.02% IGEPAL (Sigma, St Louis, MO), 5mM
K3Fe(CN)6 (Sigma, St Louis, MO), 5mM K4Fe(CN)6 3H2O2 (Sigma, St
Louis, MO) in PBS at 30°C overnight. Embryos were then washed in PBS
and postfixed in 4% paraformaldehyde for 45min prior to dehydration and
paraffin embedding (Hens et al., 2005). Tissue blocks were cut into 6μm
sections for evaluation of X-gal staining.
Calvarial osteoblast preparation and analysis
Calvariae were isolated from 3-day-old wild-type and Col I–Wdr5 mice
according to a standard protocol (Divieti et al., 1998; Sooy et al., 2005). Alkaline
phosphatase activity was evaluated from 4 to 25 days in culture. Alkaline
phosphatase activity in cell lysates was assessed in assay buffer (50mM Tris–
HCl pH 7.6 and 0.1% Triton X-100) containing 1.5M 2-amino-2-methyl-1-
propanol for 1h at 37°C using p-nitrophenylphosphate as a substrate. The
release of p-nitrophenol was monitored by measuring absorbance at 405nm.
Mineralized matrix formation was evaluated from 14 to 25 days in culture.
Calcium accumulation in the matrix was quantitated by solubilizing the
deposited calcium with 0.6 N HCl. The samples and a standard curve of calcium
carbonate were reacted with methylthymol blue and measured spectrophoto-
metrically at 620nm.
Western analyses
Cells were lysed in 25mM Tris–HCl pH 7.4, 150mM NaCl, 1mM CaCl
and 1% Triton after 4 and 7 days in culture. Five micrograms of protein
was subjected to SDS-PAGE under reducing conditions. After transfer to
Hybond ECL (Amersham, Piscataway, NJ), membranes were blocked in
PBS containing 1% BSA and 5% non-fat dry milk for 1h at room
temperature. Membranes were incubated with anti-β-catenin (BD Bios-
ciences, Franklin Lakes, NJ, USA) or anti-OPG (Santa Cruz Biotechnology
Inc, Santa Cruz, CA) at 4°C overnight followed by washes and
immunodetection with a peroxidase-conjugated goat antimouse IgG or
goat antirabbit IgG, respectively (Santa Cruz Biotechnology Inc., Santa
Cruz, CA). Immunoreactive proteins were visualized using a chemilumi-
nescence detection kit (NEN, Boston, MA) according to the manufacturer's
instructions.
Statistical analysis
Student's paired t test was used to evaluate differences between calvarial
osteoblast cultures isolated from wild-type and transgenic mice at each time
point. A P value <0.05 was considered statistically significant.Results
Wdr5 accelerates osteoblast differentiation in vitro and is
developmentally expressed in osteoblasts during endochondral
bone formation (Gori and Demay, 2004; Gori et al., 2001). To
identify a role for Wdr5 in osteoblast differentiation, in vivo
transgenic mice, overexpressing Wdr5 under the control of the
2.3-kb fragment of the mouse α(1) I collagen promoter (Col I–
Wdr5), were generated (Fig. 1A). This fragment has been
shown to target expression of transgenes specifically to
osteoblasts and odontoblasts but not to other type I collagen-
producing cells and is active at 13.5dpc (Rossert et al., 1995).
Five potential founders were identified by PCR analyses of
genomic DNA, three of which had a single transgene integration
site on Southern analysis (data not shown). Northern analyses of
calvarial RNA isolated from transgene positive and transgene
negative offspring of these three potential founders identified
two true founders with varying degrees of transgene expression
(Fig. 1B). Qualitatively similar results were obtained with both
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most profound phenotype being present in homozygous
transgene positive mice from line B. Mice from line B were
used for these studies. To ensure that the transgene was
specifically targeted to cells of the osteoblastic lineage,
transgene expression was analyzed by in situ hybridization
using a probe complementary to the bGH polyadenylation
sequence, which does not recognize the endogenous Wdr5
transcript. As shown in Fig. 2A, the transgene was specifically
expressed in the bone collar, primary spongiosa and cortical
bone of heterozygous (het) Col I–Wdr5 and homozygous (hom)
Col I–Wdr5 mice. No signal was observed with Wdr5 sense
riboprobe (data not shown). Unlike the endogenous Wdr5 gene
(Fig. 2B), the transgene was not expressed in the growth plate.
To assess whether targeted expression of Wdr5 to osteoblasts
results in acceleration of skeletal development, whole-mount
skeletons from het Col I–Wdr5, hom Col I–Wdr5 and wild-type
fetuses at embryonic day 14.5 were analyzed. As shown in Fig.
3A, the expression of the transgene resulted in an overall bigger
skeleton in a gene dosage-dependent fashion [wt<het Col I–
Wdr5<hom Col I–Wdr5]. To further characterize the pheno-Fig. 3. The expression of the transgene leads to a larger skeleton and accelerated vasc
(A) of 14.5dpc wt, het Col I–Wdr5 and hom Col I–Wdr5 embryos. (B) Hematoxylin
Wdr5 and hom Col I–Wdr5 embryos at 14.5dpc. Double arrowheaded lines indi
Representative sections of forelimbs from at least four wt, het Col I–Wdr5 and hom
performed on humeri isolated from 14.5dpc embryos using an anti-CD31 antibody.
vessels invading the hypertrophic chondrocyte layer.type of the transgenic mice, histological analyses of humeri
isolated from 14.5dpc embryos were performed. As shown in
Fig. 3B, the humeri of Col I–Wdr5 embryos were longer than
those isolated from wild-type littermates at 14.5dpc. While no
difference was observed in the length of the zone of flat and
round proliferating chondrocytes, the hypertrophic layer was
expanded in Col I–Wdr5 embryos compared to wild-type
littermates (Fig. 3B and Table 1) with a more profound
phenotype being observed in humeri isolated from hom Col I–
Wdr5 embryos. This expansion of the hypertrophic chondrocyte
layer was not observed at 13.5dpc (data not shown), prior to the
appearance of osteoblasts in the bone collar, suggesting that the
chondrocyte phenotype is a paracrine consequence of Wdr5
overexpression in the osteoblasts of the bone collar. As shown
by immunostaining for CD31, blood vessels were present in the
humeri isolated from both transgene positive embryos and wild-
type embryos at 14.5dpc. However, there was evidence of
vascular invasion into the humeri isolated from transgene
positive embryos, whereas in the humeri isolated from wild-
type embryos blood vessels were present only in the bone collar,
suggesting that overexpression of Wdr5 resulted in acceleratedular invasion. Alcian Blue and Alizarin Red staining was performed on skeletons
and eosin. H&E staining was performed on humeri isolated from wt, het Col I–
cate the hypertrophic chondrocyte layer and arrows point to the bone collar.
Col I–Wdr5 embryos at 14.5dpc are shown. (C) Immunohistochemistry was
Arrows indicate blood vessels in the bone collar and arrowheads indicate blood
Table 1
Length of humeri, round and flat proliferating chondrocytes and hypertrophic
chondrocytes layers
Genotype Round and flat
proliferating
chondrocytes
Hypertrophic
chondrocytes
Length of the
humeri
Wt 0.862 ± 0.02
(n = 8)
0.416 ± 0.02
(n = 8)
1.84 ± 0.03
(n = 5)
het Col I–Wdr5 0.898 ± 0.03
(n = 7)
0.492 ± 0.01
(n = 7)*
2.085 ± 0.03
(n = 6)**
hom Col I–Wdr5 0.815 ± 0.03
(n = 4)
0.530 ± 0
(n = 4)**
2.165 ± 0.07
(n = 4)**
Measurements are expressed in mm ± SEM. *P < 0.001 and **P < 0.005 by
Student's t test.
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isolated from 7- (Figs. 4A and B) and 9- (Figs. 4C and D) day-
old mice demonstrated accelerated formation of the secondary
ossification center, confirming persistent acceleration of
endochondral bone development in transgene positive mice
postnatally (arrows in Fig. 4).
To confirm that targeted expression of Wdr5 to osteoblasts
results in accelerated osteoblast differentiation, in situ hybrid-
ization analyses were performed using type I collagen (Col I), a
specific marker for preosteoblasts and osteoblasts (Stein et al.,
2004), and osteopontin (OP), a marker for mature osteoblasts
and for terminally differentiated hypertrophic chondrocytes
(Gerstenfeld and Shapiro, 1996; Stein et al., 2004). As shown inFig. 4. Expression of the transgene leads to accelerated formation of the secondary os
B) and 9- (E and F) day-old wt and het Col I–Wdr5 mice. (C and D) Magnification of
indicate the secondary ossification center. Representative sections of hindlimbs fromFig. 5, Col I was expressed more extensively and at higher
levels in the bone collar of humeri isolated from 14.5dpc het
Col I–Wdr5 embryos compared to those of their wild-type
littermates, demonstrating accelerated maturation of the bone
collar. The expression domain of OP was more extensive in the
bone collar and interestingly was more expanded in the
hypertrophic chondrocyte layer of the humeri isolated from
het Col I–Wdr5 embryos compared to that of their wild-type
littermates at 14.5dpc (Fig. 5). Because the expression of type X
collagen, a marker for hypertrophic chondrocytes (Schmid and
Linsenmayer, 1985), overlapped that of osteopontin in the wild-
type and het Col I–Wdr5 embryos (data not shown), the
expansion of the domain of osteopontin-expressing cells was
due to an expansion of the terminally differentiated hypertro-
phic chondrocyte layer. The acceleration in osteoblast differen-
tiation was also reflected by more extensive mineral deposition
in the bone collar of the het Col I–Wdr5 embryos at 14.5dpc
(Fig. 5). This acceleration of osteoblast differentiation persists
in newborn mice, as shown by higher levels of osteocalcin (OC)
expression in the primary spongiosa and cortical bone of tibiae
isolated from transgene positive mice compared to their wild-
type littermates (Fig. 5).
To define the molecular basis for this accelerated osteoblast
differentiation, the Wnt signaling pathway, known to play a
crucial role in osteoblast differentiation, was investigated. The
expression of β-catenin, a key mediator of the canonical Wnt
signaling pathway, was examined in humeri isolated from wild-sification center. H&E staining was performed on tibiae isolated from 7- (A and
the secondary ossification center shown in panels A and B, respectively. Arrows
three wt and het Col I–Wdr5 mice are shown.
Fig. 5. Molecular analyses of osteoblast differentiation. Sections of humeri of wt
and het Col I–Wdr5 embryos are shown. Type I collagen (Col I), ostepontin
(OP) and osteocalcin (OC) antisense riboprobes were radiolabeled with 35S-UTP
to a specific activity of at least 108cpm/μg of template. von Kossa staining.
Deposited mineral is stained black by von Kossa staining. Representative
forelimbs from at least four wt and het Col I–Wdr5 littermates are shown.
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nuclear β-catenin protein were found in the bone collar of
humeri isolated from het Col I–Wdr5 embryos compared to
humeri isolated from wild-type embryos (Figs. 6A–B). To
further confirm the activation of canonical Wnt signaling
pathway, het Col I–Wdr5 mice were crossed with TOPGAL
mice to obtain mice expressing both the Wdr5 and the lacZ
transgenes (Col I–Wdr5;TOPGAL). TOPGAL transgenic mice
express the lacZ gene under the control of a regulatory sequence
consisting of three consensus LEF/TCF-binding motifs up-
stream of a minimal c-fos promoter. Since when β-catenin is
activated, it translocates to the nucleus, where in concert withTCF, it modulates gene expression, β-gal activity in these mice
reflects activation of the canonical Wnt signaling pathway. As
expected, no difference in β-gal activity was observed in
chondrocytes since the Wdr5 transgene was specifically
expressed in osteoblasts (Figs. 6C–D). However, more exten-
sive β-gal staining was observed in the bone collar of 14.5dpc
Col I–Wdr5;TOPGAL embryos compared to wt;TOPGAL
embryos (Figs. 6E–F), demonstrating that acceleration of
osteoblast differentiation by Wdr5 is associated with earlier
activation of the canonicalWnt signaling pathway in osteoblasts.
To demonstrate that the effects of Wdr5 on osteoblast
differentiation were cell-autonomous, primary calvarial
osteoblasts were isolated from 3-day old het Col I–Wdr5,
hom Col I–Wdr5 and wild-type mice. Analyses investigating
the time of onset and level of expression of markers of
osteoblast differentiation were performed. It is generally
accepted that the acquisition of the mature osteoblast
phenotype is characterized by the ability of these cells to
synthesize Alkaline Phosphatase (AP), and that an increase
in the specific activity of this enzyme is strongly correlated
with a shift to a more differentiated state (Lian and Stein,
1993). As shown in Fig. 7A, by 4 days in culture,
osteoblasts isolated from the het Col I–Wdr5 and hom Col
I–Wdr5 show a 2.3-fold increase in AP activity compared to
that of the cells isolated from wild-type mice. After 7 days
in culture, het Col I–Wdr5 and hom Col I–Wdr5 osteoblasts
maintained a significantly higher AP activity compared to
the wild-type osteoblasts. However, the AP activity of the
wild-type osteoblasts increased to that of the het Col I–
Wdr5 and hom Col I–Wdr5 osteoblasts after 25 days in
culture (data not shown).
The final stage of osteoblast differentiation is the
formation of mineralized matrix nodules. Quantification of
calcium deposited into the cultures revealed an increase in
the calcium content of the het Col I–Wdr5 and hom Col I–
Wdr5 cultures after 14 days compared to the wild-type
cultures (Fig. 7B). However, by day 25, no statistically
significant differences were observed among the cultures
isolated from wild-type, het Col I–Wdr5 and hom Col I–
Wdr5 mice. These data demonstrate that targeted over-
expression of Wdr5 to osteoblasts accelerates osteoblast
differentiation during skeletal development. To confirm the
in vivo analyses demonstrating that osteoblast differentiation
was associated with enhanced activation of the canonical
Wnt pathway, Western analyses were performed to examine
the level of β-catenin. As shown in Fig. 7C, β-catenin
levels were higher in calvarial osteoblasts isolated from het
Col I–Wdr5 and hom Col I–Wdr5 mice compared to
calvarial osteoblasts isolated from wild-type mice, confirm-
ing that targeting expression of Wdr5 to osteoblasts results
in enhanced activation of the canonical Wnt signaling
pathway during osteoblast differentiation. It has been
recently demonstrated that osteoprotegerin (OPG) is a target
of the canonical Wnt signaling pathway (Glass et al., 2005).
Confirming that the acceleration of osteoblast differentiation
by Wdr5 is associated with the activation of the canonical
Wnt signaling pathway, OPG protein levels were also higher
Fig. 6. Col I–Wdr5 transgenic mice demonstrate enhanced activation of the canonical Wnt signaling in osteoblasts. Panels A–B Fluorescent immunohistochemistry
with an anti-β-catenin antibody. Nuclear β-catenin was evaluated in sections of humeri of wt and het Col I–Wdr5 embryos. Filled arrowheads indicate osteoblasts
expressing β-catenin. Open arrowheads point to osteoblasts not expressing nuclear β-catenin. Panels C–F LacZ expression was evaluated in sections of humeri of Col
I–Wdr5;TOPGAL and wt;TOPGAL embryos. (E and F) Higher magnification of boxed area shown in panels C and D. Arrows indicate X-gal staining of osteoblasts in
the bone collar, unstained osteoblasts are indicated by arrowheads. Representative forelimbs from two 14.5dpc Col I–Wdr5;TOPGAL and wt;TOPGAL littermates are
shown.
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compared to calvarial osteoblasts isolated from wild-type
mice (Fig. 7D).
Discussion
Characterization of skeletal development in embryos over-
expressing Wdr5 in osteoblasts demonstrates that targeted
overexpression of this WD repeat-containing protein to
osteoblasts results in accelerated endochondral bone formation
during skeletal development.Fig. 7. Wdr5 enhances calvarial osteoblast differentiation. (A) Alkaline phosphatase
bar), het Col I–Wdr5 (gray bar) and hom Col I–Wdr5 (black bar) mice were assessed
three independent calvarial osteoblast preparations. The results are the mean±SEM
osteoblasts isolated from wt (1), het Col I–Wdr5 (2) and hom Col I–Wdr5 transgeni
calvarial osteoblasts isolated from wt (1), het Col I–Wdr5 (2) and hom Col I–Wdr5 tr
an actin antibody confirms equal protein loaded. Data shown are representative of tWdr5 is a member of a family of structurally conserved
proteins, the WD-40 repeat proteins (Gori et al., 2001). These
proteins contain 4 or more copies of a conserved Trp-Asp motif,
the so-called WD-40 repeat (Neer et al., 1994; Neer and Smith,
1996, 2000; Smith et al., 1999). Each of the WD-repeats are
though to fold into four antiparallel β strands radiating outward
from a central axis, leading to the formation of a “β-propeller”
structure which forms a scaffold for binding of other proteins.
Several WD-40 proteins interact with histone deacetylases and
regulate the expression of genes involved in the cell cycle and
chromatin structure (Ahmad et al., 1999; Mitsuzawa et al.,activity and (B) calcium content of calvarial osteoblasts isolated from wt (open
from 4 to 25 days in culture. Data shown are representative of that obtained with
. *P<0.05, **P<0.005 by Student's t test. (C) β-Catenin levels in calvarial
c mice (3) assessed by Western analysis at 4 days in culture. (D) OPG levels in
ansgenic mice (3) assessed by Western analysis at 7 days in culture. Control with
hat obtained with two independent calvarial isolations.
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related Set1/Ash2 histone methyltransferase (HMT) complex
involved in activation of transcription via methylation of
histone H3 lysine 4 (H3 K4) (Wysocka et al., 2003) and the
human WDR5 has also been shown to be essential for H3 K4
methylation and for normal vertebrate development (Dou et al.,
2005; Wysocka et al., 2005). WDR5 associates and regulates
the circadian histone methylation of the clock protein, PERIOD-
1 (Per 1), a key player in the circadian rhythms of mammalian
cells (Brown et al., 2005). Taken together, these observations
suggest that Wdr5, via its WD repeats, associates with nuclear
proteins that play a role in chromatin remodeling thereby
regulating gene expression. Interestingly, it has been recently
shown that Per null mice display a higher bone mass due to an
increase in bone formation (Fu et al., 2005), suggesting that
accelerated osteoblast differentiation by Wdr5 may also be
associated with regulation of the circadian rhythm genes.
Our analyses demonstrate that Wdr5 plays a role in
endochondral and intramembranous ossification during devel-
opment. Because skeletal development is regulated by several
factors, it is likely that Wdr5 interacts with or modulates the
expression of target genes that accelerate osteoblast differenti-
ation. Several studies have demonstrated that the canonical Wnt
signaling pathway regulates several key processes during
skeletal development, including osteoblast differentiation and
postnatal bone mass (Akiyama et al., 2004; Day et al., 2005;
Gong et al., 2001; Hens et al., 2005; Hill et al., 2005; Hu et al.,
2005; Johnson et al., 2004; Kato et al., 2002; Westendorf et al.,
2004). Wnt proteins signal through the Frizzled family of
receptors (Fzds) and the co-receptors Lrp5 and Lrp6 (low-
density lipoprotein receptor-related proteins), leading to
stabilization of β-catenin and activation of Lef/Tcf target
genes. Interestingly, DasGupta et al. (2005), using a genome-
wide RNAi screen in Drosophila, have recently identified WD
repeat proteins as potential regulators of the canonical Wnt-
Wingless pathway in Drosophila. Thus, the finding that Col I–
Wdr5 transgenic mice display an earlier activation of canonical
Wnt signaling in osteoblasts identifies Wdr5 as a potential
positive regulator of the canonical Wnt signaling pathway in
osteoblasts during mammalian skeletal development. In 293
cells, loss of WDR5 attenuates the expression of HoxC8, a
transcription factor involved in anterior/posterior patterning
during development (Wysocka et al., 2005). Since HoxC8
induces the expression of Fzd2, a Wnt co-receptor (Lei et al.,
2005), it is possible that induction of HoxC8 and thus Fzd2,
enhanced the activation of the canonical Wnt signaling pathway
observed with Wdr5 overexpression.
The overexpression of Wdr5 in Col I-expressing osteoblasts
results in an expansion of the late hypertrophic chondrocyte
layer that accounts for an increase in the length of humeri
observed in transgene positive embryos. Longitudinal bone
growth occurs by endochondral bone formation and is
dependent upon the rate of chondrocyte proliferation and
hypertrophic differentiation, a process regulated by several
signaling pathways including the Ihh, PTHrP, BMP and FGF
pathways (Kronenberg, 2003). Since the Col I–Wdr5 transgene
is specifically expressed in osteoblasts, our findings suggest thatWdr5, overexpressed in the bone collar, regulates the activity of
one or more of these pathways that in turn regulates
chondrocyte maturation. Characterization of the molecular
consequences of Wdr5 overexpression in osteoblasts is
expected to elucidate which of these pathways underlie the
paracrine actions of Wdr5 that regulate longitudinal skeletal
growth.
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